SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-078525
Filing Date
2015-11-13
Accepted
2015-11-13 08:46:37
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a15-19316_110q.htm 10-Q 1817978
2 EX-10.1 a15-19316_1ex10d1.htm EX-10.1 20233
3 EX-31.1 a15-19316_1ex31d1.htm EX-31.1 11383
4 EX-31.2 a15-19316_1ex31d2.htm EX-31.2 10749
5 EX-32.1 a15-19316_1ex32d1.htm EX-32.1 9308
  Complete submission text file 0001104659-15-078525.txt   8529206

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT neos-20150930.xml EX-101.INS 1767547
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT neos-20150930.xsd EX-101.SCH 65909
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT neos-20150930_cal.xml EX-101.CAL 56740
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT neos-20150930_def.xml EX-101.DEF 362828
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT neos-20150930_lab.xml EX-101.LAB 619946
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT neos-20150930_pre.xml EX-101.PRE 559722
Mailing Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050
Business Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050 972.408.1360
Neos Therapeutics, Inc. (Filer) CIK: 0001467652 (see all company filings)

IRS No.: 270395455 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37508 | Film No.: 151227022
SIC: 2834 Pharmaceutical Preparations